DMT310-009 Topical in the Treatment of Acne Vulgaris
Status:
Recruiting
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder
mixed with diluent in male and female patients with moderate to severe facial acne vulgaris